Skip to content

Advertisement

  • Oral presentation
  • Open Access

Design considerations in the development of a core outcome set

  • 1,
  • 2,
  • 3,
  • 3,
  • 1 and
  • 4
Trials201314 (Suppl 1) :O68

https://doi.org/10.1186/1745-6215-14-S1-O68

  • Published:

Keywords

  • Otitis Medium
  • Stakeholder Group
  • Cleft Palate
  • Specialist Nurse
  • Otitis Medium With Effusion

No gold standard method currently exists for the development of a core outcome set (COS) although key issues to consider have been identified [1]. Methodological decisions in the design of a project to develop a COS for otitis media with effusion (OME) in children with cleft palate (CP) will be explained.

Stakeholder groups

Clinicians involved in the management of OME were identified as: ENT surgeons; audiologists; cleft surgeons; speech and language therapists; specialist nurses. Discussions with CLAPA patient groups resulted in a Delphi for patients (7-11, 12-16 years), their parents and adults with CP and OME.

Separate Delphi panels

A Delphi exercise has been undertaken with each clinical stakeholder group separately. This method does not assume that different stakeholder groups will have the same outcome priorities.

Describing outcomes for patients and their parents

A lay description written for each outcome was reviewed by CLAPA groups and reading age assessed. Understanding was tested in a subsample using the think aloud method.

Delivery of the Delphi online

Each round of the Delphi was delivered online using a bespoke system that managed participation invitations , reminders, data collection and reporting.

Integration of clinical and patient views

Results of the separate Delphi surveys for each stakeholder group will be shared with all participants with an opportunity to re-score. Clinicians, adults, patients and their parents who have taken part in a Delphi panel/qualitative interview will be invited to a consensus meeting, facilitated by a Study Advisory Group and CLAPA members, to discuss the final COS.

Authors’ Affiliations

(1)
The Healing Foundation Cleft and Craniofacial Clinical Research Centre, University of Manchester, Manchester, UK
(2)
Central Manchester University Hospitals NHS Foundation Trust, Manchester, UK
(3)
School of Nursing, Midwifery & Social Work, University of Manchester, Manchester, UK
(4)
Department of Biostatistics, University of Liverpool, Liverpool, UK

References

  1. Williamson PR, Altman DG, Blazeby JM, Clarke M, Devane D, Gargon E, Tugwell P: Developing core outcome sets for clinical trials: issues to consider. Trials. 2012, 13: 132-10.1186/1745-6215-13-132.PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© Harman et al; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate. Please note that comments may be removed without notice if they are flagged by another user or do not comply with our community guidelines.

Advertisement